2023 DTRF Annual Report

The DTRF Annual Patient Meeting (cont.) Ryan Brunsing, MD, PhD , Clinical Assistant Professor of Radiology, Director of MRI, Stanford University - “MRI-guided cryoablation and HIFU in the treatment of desmoid tumors.”

Eldad Elnekave, MD , Director, Kahn Unit for Interventional Oncology, Shaare Tzedek Medical Center (Israel) - “Arterial doxorubicin eluting embolization (DEE) as a desmoid tumor treatment.”

Mrinal Gounder, MD , Associate Professor, Sarcoma Medical Oncologist and Early Phase Drug Development, Memorial Sloan Kettering Cancer Center - “RINGSIDE Phase 2/3 trial of AL102 for treatment of desmoid tumors: updated Phase 2 results.”

Gabe Augdahl , Desmoid Tumor Patient

Dr. Alessandro Gronchi presents to patients, caregivers and clinicians at the DTRF Annual Patient Meeting in Philadelphia

21

Made with FlippingBook Online newsletter maker